Hims & Hers Health HIMS
NYSE HIMS
$32.26 +1.17 (+3.76%)
At close: Aug 20, 2026 · 3:01 PM UTC

Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026)

Hims & Hers Health (HIMS) posted Change in Accured Expenses of $10.0 million for Q1 2026, up 625.22% sequentially from -$1.9 million in Q4 2025, and up 130.2% YoY from $4.4 million in Q1 2025.

Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026) Analysis & Trends

Hims & Hers Health has reported Change in Accured Expenses for 8 years, with the latest figure at $10.0 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 130.2% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.4 million (down 222.99% YoY) and the FY2025 annual result came in at -$43.1 million, down 280.96% from the prior year.
  • Change in Accured Expenses rose to $10.0 million in Q1 2026 per HIMS's latest filing, from -$1.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $14.0 million in Q3 2024 and troughed at -$52.9 million in Q3 2025.
  • A 5-year average of $481588.2 and a median of $3.3 million in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 565.29% in 2022, then surged 507.26% in 2024.
  • Over 5 years, Change in Accured Expenses stood at -$4.6 million in 2022, then surged by 134.96% to $1.6 million in 2023, then soared by 507.26% to $9.8 million in 2024, then sank by 119.48% to -$1.9 million in 2025, then surged by 625.22% to $10.0 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered $10.0 million, -$1.9 million, and -$52.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn 82.00 Mn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Hims & Hers Health 7.50 Bn 6.66 Bn 480.80 Mn 79.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 79.51 Mn
Jun 30, 2026 79.51 Mn
Mar 31, 2026 10.02 Mn
Mar 31, 2026 10.02 Mn
Dec 31, 2025 -1.91 Mn
Dec 31, 2025 -1.91 Mn
Sep 30, 2025 -52.88 Mn
Sep 30, 2025 -52.88 Mn
Jun 30, 2025 7.39 Mn
Jun 30, 2025 7.39 Mn
Mar 31, 2025 4.35 Mn
Mar 31, 2025 4.35 Mn
Dec 31, 2024 9.79 Mn
Dec 31, 2024 9.79 Mn
Sep 30, 2024 14.03 Mn
Sep 30, 2024 14.03 Mn
Jun 30, 2024 2.23 Mn
Jun 30, 2024 2.23 Mn
Mar 31, 2024 -2.26 Mn
Mar 31, 2024 -2.26 Mn